The Rab32 small GTPase is required for efficient cross-priming of CD8 <sup>+</sup> T cells against cell-associated antigens by XCR1 <sup>+</sup> type 1 DCs <i>in vivo</i>
Naman Tandon(Centre National de la Recherche Scientifique), Pierre Guermonprez(Institut Pasteur)
Cited by 1
Related Papers
TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
|Nature Communications|2021|71
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors
|Nature Communications|2024|44